SCHEMBL25519911

SCHEMBL25519911

FC1(F)CC(Nc2ncc3c(-c4ccc5nccnc5c4)c[nH]c3n2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 3/20 0.41
▸ CLK2 P49760 1/20 0.41
▸ CLK3 P49761 1/20 0.41
▸ BRD4 O60885 2/20 0.38
▸ CCNK O75909 6/20 0.37
▸ CDK12 Q9NYV4 6/20 0.37
▸ CCNT1 O60563 4/20 0.37
▸ CCNE1 P24864 4/20 0.37
▸ CDK2 P24941 4/20 0.37
▸ CDK9 P50750 4/20 0.37
▸ PIM1 P11309 3/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ DYRK1B Q9Y463 2/20 0.36
▸ CDK7 P50613 2/20 0.35
▸ CCNH P51946 2/20 0.35
▸ MNAT1 P51948 2/20 0.35
▸ IDH1 O75874 3/20 0.34
▸ IDH2 P48735 1/20 0.34
▸ MAP3K11 Q16584 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30348643 1.00 DYRK1A (0.41) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL25519916 0.90 BRD4 (0.41) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL30346467 0.90 BRD4 (0.41) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL30406904 0.89 DYRK1A (0.53) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL25157418 0.89 DYRK1A (0.53) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL30348582 0.88 DYRK1A (0.42) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL25522637 0.88 DYRK1A (0.42) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL25522638 0.88 DYRK1A (0.42) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL25158454 0.85 CDC7 (0.47) DYRK1ACLK2CLK3BRD4CCNK
SCHEMBL25157431 0.85 TDO2 (0.49) DYRK1ACLK2CLK3BRD4CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2025-04-24 — — US claimed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US disclosed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK2 466/4885CLK3 1147/4885
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK2 466/4885CLK3 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback